Blue Horseshoe Stocks: SPY Calls & More


We are wrapping up a very solid week, which even included a twenty-bagger (NFLX $300 Calls, +2069%). This morning, with the markets appearing to be geared toward  bullish finish to the week, we will entertain a range of SPY Calls, for the possibility of some good daytrades to really end things on a high note going into the upcoming long weekend.

The SPY is our go-to target when not a lot else is jumping off of the scanner, and we’ve played it successfully on more occasions to count. The most recent being a couple of sets of ideas we made just prior to the New Year, which resulted in gains ranging from 300-600%

Today, we are going to be tracking the SPY Weekly $263.50-265 Calls.*

Bonus Ideas:
JBHT 02/15 $100 & $105 Calls
CGC Weekly $43-44.50 Calls*

*Please do not attempt to trade weekly options on a Friday unless you an advanced level trader with disposable funds.

Extended Watchlist:

Incoming search terms:

  • children8en
  • driver71l

Blue Horseshoe Stocks: Fresh Options Ideas & More

India Globalization Capital, Inc. IGC – Update

As we were mentioning yesterday morning, ICG was a near-perfect bottom call we made roughly three weeks ago in our report on September 10th and thereafter we would observe a low of 1.03.

For the past couple of weeks the stock has been on fire, gaining ground by leaps and bounds, and yesterday it recorded yet another huge session. From a daily low of  9.50 the stock ran to a new high of 14.58, for an intraday gain of 53%

From our initially observed low midway through last month, that marks an overall increase of 1316% Cheers to any of our readers who have been in on this mega-runner!

Tesla Inc TSLA – Recap

Yesterday morning we mentioned that our idea from Tuesday morning, the TSLA Weekly $300-310 Calls, most likely stood to gain even more ground based on the stock’s premarket activity.

As it turned out, we were absolutely correct, with each of the five contracts we designated as items of interest extending their highs on the day. Here are the updated figures from Tuesday’s session through yesterday’s closing bell:

$300 Calls – Range: 11.10-18.60 – Max Gain: 68%
$302.50 Calls – Range: 10.00-16.25 – Max Gain: 62%
$305 Calls – Range: 8.65-15.30 - Max Gain: 77%
$307.50 Calls – Range: 7.70-13.45 – Max Gain: 75%
$310 Calls – Range: 6.60-12.00 – Max Gain: 82%

Tesla is gapping up today and looks to be ready to push these contracts deep in the money, so we’ll expect to see these ranges and possible gains extended even further from here.

Fresh Options  Ideas:
Petroleo Brasiliero S.A. (Petrobras) PBR Weekly $13.50 & $14 Calls
Marriot Vacations Worldwide Corp. VAC 11/16 $105-115 Calls

Extended Watchlist: 

Blue Horseshoe Stocks: XXII Update & More

22nd Century Group, Inc. XXII

It was back on November 7th that we highlighted a large group of cannabis stocks, and professed our unyielding interest in the space as a whole. XXII was among those that we specifically highlighted as promising pot stocks in that report, and despite it being more than 8 weeks later, the stock has continually bulled its ways to new highs ever since.

We wanted to swing back around this morning to outline the excellent run it has been on since November. Subsequent to our report on the 7th the stock saw an absolute bottom of 2.00 even before beginning its months-long ascent. Yesterday the stock reached yet another new high of 3.85, marking an overall upswing of 93%

Yield10 Bioscience, Inc. YTEN

Following a huge single session run in early December, YTEN was unable to hold onto any of the ground it had gained, and with the ‘help’ of a massive public offering, continued to descend until recently.

This week, the stock has begun to show signs of a bottom bounce, and we’re going to want to add it to the radar on a recovery watch. As you can see form the chart snapshot included below, there is a lot of room for a potential surge, including a gap to fill to the upside.

Extended Watchlist:

Blue Horseshoe Stocks: Bottom-Watch Plays & More

Soligenix, Inc. SNGX

Catching our eye off of the scanner this morning is SNGX. The stock has recently made its way toward oversold territory, is trading at a relative bottom, and we’re noticing a positive funding-related PR hitting the wires today, so we’re going to designate this as a fresh news bottom-watch play.

As you can see on the snapshot of the chart below, the past couple of sessions have seen higher lows registered off of that bottom, so we’ll look for SNGX to continue that trend, possibly with the aid of this morning’s PR. The first area of resistance it needs to contend with en route to its moving averages will be a previous support level from May (1.36), so that will be the first benchmark we’d like to see broken once a rebound begins to occur. .

PRINCETON, N.J., Aug. 19, 2015 /PRNewswire/ – Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases (NIAID) has exercised its option to advance the development of Soligenix’s heat stabilized ricin toxin vaccine, RiVax™ >> FULL PR

Cannabis Science, Inc. CBIS

We tagged CBIS in yesterday’s premarket report in time to catch a nice intraday move out of the stock. We suspected that the momentum generated by some big news the day before could carry over into yesterday’s session, and that’s just what happened.

The stock ran from a daily low of .0349 to a high of .048, a respectable 38% jump which occurred on volume of roughly 8X the monthly average.

Corbus Pharmaceutical Holdings, Inc. CRBP – Chatroom Call

We also want to take the opportunity to highlight a call made by one of our daily traders chatroom* members. Well in advance of the opening bell ‘GTRudeBoy’ directed the room to watch CRBP, and it resulted in a nice chance for all to profit.

The stock opened at 2.80 and dipped to 2.57 before rallying to its high of 4.22; that’s an intraday move of 64% Cheers go out to ‘GTRudeBoy’ for alerting everyone to the interesting premarket activity.

*This serves as yet another great example of why we run our daily chats. We are stronger together! That’s why we routinely encourage any of our readers who’d like to get involved with our traders chats, simply send a Skype contact request to username stocksumo with “Traders Chat” in the special note. We’d be happy to have you join the fun!

Extended Watchlist:
AURI(Share reduction news)
NTAP ($31.50-32.50 Weekly Calls)
BWLD(Sept.18 $200 Calls)
CJES, ABUS(Annual Lows, Both on Bottom-Watch)

Blue Horseshoe Stocks: NUGN on Bottom-Watch & More

NuGene International, Inc. NUGN

We’re mentioning NUGN for the first time this morning on the heels of some interesting events that have recently unfolded. The stock had been on a sustained uptrend for over two months that was apparently the product of a massive promotion (in which we played no role) which resulted in the PPS running from below $2 to more than $4.

On Wednesday, the company issued a public statement to clarify that it was not involved in promotional activities of any sort >>Read PR

What followed yesterday was a massive sell-off to the tune of nearly 40%, and that’s where we enter the picture. Regardless of the catalysts behind NUGN’s gradual rise and rapid fall, we’re only interested in the chart activity that will follow. We’re going to highlight NUGN as a bottom-watch play, because the resultant bounce when the stock finds a solid level of support could make quick-strike gains a snap for those paying close enough attention.

Fresh News Plays

We’re going to tag both of the following for observation today after each published notable premarket PR’s this morning:

AmeriMex International, Inc. AMMX

In addition to announcing the latest in a long string of recently secured purchase agreements (links below), the AMMX chart is looking rather bullish at the moment.


Corbus Pharmaceuticals Holdings, Inc. CRBP

We’ll also keep an eye on CRBP, which has some FDA-related news out today.

Corbus Pharmaceuticals Announces FDA Orphan Drug Designation for Resunab(TM) for the Treatment of Systemic Sclerosis (Scleroderma) (Fri 8:12AM EDT)

Options Idea:

Twitter, Inc. TWTR is responding well in the wake of the revelation that its current CEO will be stepping down on July 1st. We’re going to put TWTR Weekly $36-38 Calls on watch today as well, for potential daytrading opportunities.

Extended Watchlist: